Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Association of vitamin D and incident statin induced myalgia--a retrospective cohort study.

Palamaner Subash Shantha G, Ramos J, Thomas-Hemak L, Pancholy SB.

PLoS One. 2014 Feb 19;9(2):e88877. doi: 10.1371/journal.pone.0088877. eCollection 2014.

2.

Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients.

Calza L, Magistrelli E, Colangeli V, Borderi M, Contadini I, Bon I, Re MC, Viale P.

AIDS. 2017 Mar 13;31(5):681-688. doi: 10.1097/QAD.0000000000001397.

PMID:
28060020
3.

Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins.

Kurnik D, Hochman I, Vesterman-Landes J, Kenig T, Katzir I, Lomnicky Y, Halkin H, Loebstein R.

Clin Endocrinol (Oxf). 2012 Jul;77(1):36-41. doi: 10.1111/j.1365-2265.2011.04321.x.

PMID:
22211469
4.

Low plasma vitamin D levels and muscle-related adverse effects in statin users.

Eisen A, Lev E, Iakobishvilli Z, Porter A, Brosh D, Hasdai D, Mager A.

Isr Med Assoc J. 2014 Jan;16(1):42-5.

5.

Analysis of vitamin D levels in patients with and without statin-associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients.

Michalska-Kasiczak M, Sahebkar A, Mikhailidis DP, Rysz J, Muntner P, Toth PP, Jones SR, Rizzo M, Kees Hovingh G, Farnier M, Moriarty PM, Bittner VA, Lip GY, Banach M; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group.

Int J Cardiol. 2015 Jan 15;178:111-6. doi: 10.1016/j.ijcard.2014.10.118. Epub 2014 Oct 22. Review.

PMID:
25464233
6.

Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain.

Taylor BA, Lorson L, White CM, Thompson PD.

Atherosclerosis. 2017 Jan;256:100-104. doi: 10.1016/j.atherosclerosis.2016.11.011. Epub 2016 Nov 12.

PMID:
27993387
7.

Vitamin D deficiency, myositis-myalgia, and reversible statin intolerance.

Glueck CJ, Budhani SB, Masineni SS, Abuchaibe C, Khan N, Wang P, Goldenberg N.

Curr Med Res Opin. 2011 Sep;27(9):1683-90. doi: 10.1185/03007995.2011.598144. Epub 2011 Jul 6.

PMID:
21728907
8.

Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients.

Ahmed W, Khan N, Glueck CJ, Pandey S, Wang P, Goldenberg N, Uppal M, Khanal S.

Transl Res. 2009 Jan;153(1):11-6. doi: 10.1016/j.trsl.2008.11.002. Epub 2008 Dec 6.

PMID:
19100953
9.

Do women with statin-related myalgias have low vitamin D levels?

Minissian M, Agarwal M, Shufelt C, Mehta PK, Waldman T, Lentz G, Cook-Wiens G, Eastwood JA, Noel Bairey Merz C.

BMC Res Notes. 2015 Sep 17;8:449. doi: 10.1186/s13104-015-1356-9.

11.

Low vitamin D as a risk factor for the development of myalgia in patients taking high-dose simvastatin: a retrospective review.

Mergenhagen K, Ott M, Heckman K, Rubin LM, Kellick K.

Clin Ther. 2014 May;36(5):770-7. doi: 10.1016/j.clinthera.2014.02.023. Epub 2014 Apr 16.

PMID:
24742497
12.

Vitamin D status modifies the association between statin use and musculoskeletal pain: a population based study.

Morioka TY, Lee AJ, Bertisch S, Buettner C.

Atherosclerosis. 2015 Jan;238(1):77-82. doi: 10.1016/j.atherosclerosis.2014.11.012. Epub 2014 Nov 20.

13.

The relationship of vitamin D deficiency to statin myopathy.

Gupta A, Thompson PD.

Atherosclerosis. 2011 Mar;215(1):23-9. doi: 10.1016/j.atherosclerosis.2010.11.039. Epub 2010 Dec 5. Review.

PMID:
21185021
14.

Myopathy during statin therapy in the daily practice of an outpatient cardiology clinic: prevalence, predictors and relation with vitamin D.

Riphagen IJ, van der Veer E, Muskiet FA, DeJongste MJ.

Curr Med Res Opin. 2012 Jul;28(7):1247-52. doi: 10.1185/03007995.2012.702102. Epub 2012 Jun 28.

PMID:
22686958
15.

Low Vitamin D Levels and Genetic Polymorphism in the Vitamin D Receptor are Associated with Increased Risk of Statin-Induced Myopathy.

Ovesjö ML, Skilving I, Bergman P, Rane A, Ekström L, Björkhem-Bergman L.

Basic Clin Pharmacol Toxicol. 2016 Mar;118(3):214-8. doi: 10.1111/bcpt.12482. Epub 2015 Oct 1.

16.

Risk identification and possible countermeasures for muscle adverse effects during statin therapy.

Magni P, Macchi C, Morlotti B, Sirtori CR, Ruscica M.

Eur J Intern Med. 2015 Mar;26(2):82-8. doi: 10.1016/j.ejim.2015.01.002. Epub 2015 Jan 29. Review.

PMID:
25640999
17.

Contribution of vitamin D deficiency to the risk of coronary heart disease in subjects with essential hypertension.

Nargesi AA, Heidari B, Esteghamati S, Hafezi-Nejad N, Sheikhbahaei S, Pajouhi A, Nakhjavani M, Esteghamati A.

Atherosclerosis. 2016 Jan;244:165-71. doi: 10.1016/j.atherosclerosis.2015.11.020. Epub 2015 Nov 23.

PMID:
26647372
18.

Is there really a relationship between serum vitamin D (25OHD) levels and the musculoskeletal pain associated with statin intake? A systematic review.

Pereda CA, Nishishinya MB.

Reumatol Clin. 2016 Nov - Dec;12(6):331-335. doi: 10.1016/j.reuma.2016.03.009. Epub 2016 Apr 25. Review. English, Spanish.

19.

Serum 25-hydroxyvitamin D deficiency and the 5-year incidence of CKD.

Damasiewicz MJ, Magliano DJ, Daly RM, Gagnon C, Lu ZX, Sikaris KA, Ebeling PR, Chadban SJ, Atkins RC, Kerr PG, Shaw JE, Polkinghorne KR.

Am J Kidney Dis. 2013 Jul;62(1):58-66. doi: 10.1053/j.ajkd.2013.03.010. Epub 2013 Apr 23.

PMID:
23623574
20.

Higher predicted vitamin D status is associated with reduced risk of Crohn's disease.

Ananthakrishnan AN, Khalili H, Higuchi LM, Bao Y, Korzenik JR, Giovannucci EL, Richter JM, Fuchs CS, Chan AT.

Gastroenterology. 2012 Mar;142(3):482-9. doi: 10.1053/j.gastro.2011.11.040. Epub 2011 Dec 9.

Supplemental Content

Support Center